Lexpos News

MHRA Class 4 Medicines Defect Notification: Xaggitin XL Prolonged-release Tablets (Macarthys Laboratories Ltd T/A Martindale Pharma) Drug alert number: EL(26)A/35 Date issued: 20 July 2026 Macarthys Laboratories Ltd T/A Martindale Pharma has notified the MHRA of a manufacturing issue impacting several batches of Xaggitin XL Prolonged-release Tablets, due to the occurrence of incorrect tablet counts in [...]

The post MHRA Class 4 Medicines Defect Notification: Xaggitin XL Prolonged-release Tablets (Martindale Pharma) appeared first on Community Pharmacy England.

Community pharmacy owners and their teams have two opportunities to help shape the development of future NHS digital services, ensuring that pharmacy perspectives are reflected in systems designed to support both clinical care and service delivery. The opportunities relate to: An early prototype of a future Manage Your Service (MYS) claiming process for Independent Prescribing [...]

The post Help Improve Future NHS Digital Services appeared first on Community Pharmacy England.

52% of community pharmacy owners have completed the 2026/27 Community Pharmacy Assurance Framework (CPAF) screening questionnaire, with two weeks left to complete. We encourage pharmacy owners who have not yet responded to the questionnaire to ensure they do so by Friday, 31st July 2026. Completing the screening questionnaire is a Terms of Service requirement and [...]

The post CPAF Screening Questionnaire 2026/27 – two weeks left to complete appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (17/06/2026) confirmed the following list of price concessions for July 2026: Drug Pack size Price concession Aspirin 75mg gastro-resistant tablets 28 £1.90 Atorvastatin 60mg tablets 28 £5.01 Bisoprolol 2.5mg tablets 28 £1.20 Bisoprolol 3.75mg tablets 28 £1.45 Candesartan 4mg tablets 7 £1.99 Chlorpromazine 25mg tablets [...]

The post July 2026 Price Concessions 2nd Update appeared first on Community Pharmacy England.

From 1 July 2026, Rosemont Pharmaceuticals Ltd increased its list prices for several products currently listed in Category C of the Drug Tariff. Community Pharmacy England Pharmacy teams has received reports from pharmacy teams about these products being unavailable to purchase at or below the prices published in the July 2026 Drug Tariff. Under the [...]

The post July 2026 reimbursement price adjustments for Rosemont products appeared first on Community Pharmacy England.